VIA Pharmaceuticals, Inc. (Nasdaq: VIAP) announced exclusive, worldwide licensing agreements with Roche for two sets of compounds. The first was ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE